Cannabis Startup Enters USP to Innovate Medicinal Cannabis Prescription

The Canabinote startup has been approved in the selection process for the Technology-Based Companies Incubation Program at SUPERA Incubator. Joining the program connects the company directly to the innovation ecosystem of the University of São Paulo (USP) in Ribeirão Preto.

According to the company, this move is strategic for the healthcare sector. The main goal is to develop technologies that strictly base the prescription of medicinal cannabis on solid scientific evidence. The incubation aims to refine a tool focused on mitigating the insecurity that many doctors still feel when recommending cannabinoids.

A New Model for Medicinal Cannabis Prescription

The startup's proposal, which will be enhanced during the period at Supera Park, consists of reversing the logic often seen in the market. The platform structures the doctor's journey by prioritizing the therapeutic strategy before commercial choice.

The system starts with definitions based on clinical trials and validated dosages. Only after this technical step, the tool presents the available product options for prescribing medicinal cannabis.

To ensure technical neutrality, the company adopts a model where there is no charge for product registration or paid advertising. Brands are listed only if they present Certificates of Analysis (COAs) in compliance with the criteria of the Brazilian Pharmacopoeia.

Thus, the aim is to offer the doctor a neutral technical comparison. The focus remains on treatment efficacy, dissociating the prescription of medicinal cannabis from biased commercial agreements.

Technology and the Future of Prescription

During the incubation cycle, Canabinote stated that it will focus on three technological development axes. The first is Artificial Intelligence, enhancing algorithms to automate the extraction of data from new scientific studies and keep the database updated.

The second axis is interoperability with hospital management systems and electronic medical records. The goal is to integrate the prescription of medicinal cannabis into the standard flow of healthcare institutions organically.

Finally, the validation stage will involve testing the tool in a real environment. Under the technical mentorship of the park, the company will seek to measure the accuracy of the clinical recommendations generated by the platform.